|
|
- 2018
氧化还原敏感PEO-PPO-SS-DTX聚合物胶束的构建及体外抗肿瘤评价
|
Abstract:
| [1] | Tong SW, Xiang B, Dong DW, et al. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles[J]. Int J Pharm, 2012, 434(1-2): 413-419. |
| [2] | Zhang P, Zhang HY, He WX, et al. Disulfide-linked amphiphilic polymer-docetaxel conjugates assembled redox-sensitive micelles for efficient antitumor drug delivery[J]. Biomacromolecules, 2016, 17(5): 1621-1632. |
| [3] | Kenmotsu H, Tanigawara Y. Pharmacokinetics, dynamics and toxicity of docetaxel: why the Japanese dose differs from the Western dose[J]. Cancer Sci, 2015, 106(5): 497-504. |
| [4] | Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers[J]. Eur J Pharm Biopharm, 2009, 71(3): 431-444. |
| [5] | van der Veldt AA, Hendrikse NH, Smit EF, et al. Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients[J]. Eur J Nucl Med Mol Imaging, 2010, 37(10): 1950-1958. |
| [6] | Luo Y, Ling Y, Guo W, et al. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells[J]. J Control Release, 2010, 147(2): 278-288. |
| [7] | Cheng R, Feng F, Meng F, et al. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery[J]. J Control Release, 2011, 152(1): 2-12. |
| [8] | Mazzarino L, Loch-Neckel G, Dos Santos Bubniak L, et al. Nanoparticles made from xyloglucan-block-polycaprolactone copolymers: safety assessment for drug delivery[J]. Toxicol Sci, 2015, 147(1): 104-115. |
| [9] | Hermann TW, Yen WC, Tooker P, et al. The retinoid X receptor agonist bexarotene(Targretin)synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells[J]. Lung Cancer, 2005, 50(1): 9-18. |
| [10] | Zhu Y, Zhang J, Meng F, et al. cRGD/TAT dual-ligand reversibly crosslinked micelles loaded with docetaxel penetrate deeply into tumor tissue and show high antitumor efficacy in vivo[J]. ACS Appl Mater Interfaces, 2017, 9(41): 35651-35663. |
| [11] | Valle JW, Armstrong A, Newman C, et al. A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction[J]. Invest New Drugs, 2011, 29(5): 1029-1037. |
| [12] | Haag R, Kratz F. Polymer therapeutics: concepts and applications[J]. Angew Chem Int Ed Engl, 2006, 45(8): 1198-1215. |
| [13] | Han JH, Lee JY, Suh DH, et al. Electrode-impregnable and cross-linkable poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)triblock polymer electrolytes with high ionic conductivity and a large voltage window for flexible solid-state supercapacitors[J]. ACS Appl Mater Interfaces, 2017, 9(39): 33913-33924. |
| [14] | Wouters MA, Fan SW, Haworth NL. Disulfides as redox switches: from molecular mechanisms to functional significance[J]. Antioxid Redox Signal, 2010, 12(1): 53-91. |
| [15] | Betz SF. Disulfide bonds and the stability of globular proteins[J]. Protein Sci, 1993, 2(10): 1551-1558. |
| [16] | Zhou NE, Kay CM, Hodges RS. Disulfide bond contribution to protein stability: positional effects of substitution in the hydrophobic core of the two-stranded α-helical coiled-coil[J]. Biochemistry, 1993, 32(12): 3178-3187. |
| [17] | Bulaj G. Formation of disulfide bonds in proteins and peptides[J]. Biotechnol Adv, 2005, 23(1): 87-92. |
| [18] | He Z, Wang Q, Sun Y, et al. The biocompatibility evaluation of mPEG-PLGA-PLL copolymer and different LA/GA ratio effects for biocompatibility[J]. J Biomater Sci Polym Ed, 2014, 25(9): 943-964. |
| [19] | Liggins RT, Burt HM. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations[J]. Adv Drug Deliv Rev, 2002, 54(2): 191-202. |
| [20] | Mu L, Elbayoumi TA, Torchilin VP. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-α-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin[J]. Int J Pharm, 2005, 306(1-2): 142-149. |
| [21] | Lo CL, Huang CK, Lin KM, et al. Mixed micelles formed from graft and diblock copolymers for application in intracellular drug delivery[J]. Biomaterials, 2007, 28(6): 1225-1235. |
| [22] | Sanson M, Napolitano M, Yaya R, et al. Second line chemotherapy with docetaxel in patients with recurrent malignant glioma: a phase II study[J]. J Neurooncol, 2000, 50(3): 245-249. |
| [23] | Forsyth P, Cairncross G, Stewart D, et al. Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group[J]. Invest New Drugs, 1996, 14(2): 203-206. |
| [24] | Kuppusamy P, Li H, Ilangovan G, et al. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels[J]. Cancer Res, 2002, 62(1): 307-312. |
| [25] | Mohr A, Talbiersky P, Korth HG, et al. A new pyrene-based fluorescent probe for the determination of critical micelle concentrations[J]. J Phys Chem B, 2007, 111(45): 12985-12992. |
| [26] | Zhang Z, Ni J, Chen L, et al. Biodegradable and thermoreversible PCLA-PEG-PCLA hydrogel as a barrier for prevention of post-operative adhesion[J]. Biomaterials, 2011, 32(21): 4725-4736. |
| [27] | Qiu M, Ouyang J, Sun H, et al. Biodegradable micelles based on poly(ethylene glycol)-b-polylipopeptide copolymer: a robust and versatile nanoplatform for anticancer drug delivery[J]. ACS Appl Mater Interfaces, 2017, 9(33): 27587-27595. |
| [28] | Wu J, Deng C, Meng F, et al. Hyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancer[J]. J Control Release, 2017, 259: 76-82. |
| [29] | Gao C, Liu T, Dang Y, et al. pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate[J]. Carbohydr Polym, 2014, 111: 964-970. |
| [30] | Coors EA, Seybold H, Merk HF, et al. Polysorbate 80 in medical products and nonimmunologic anaphylactoid reactions[J]. Ann Allergy Asthma Immunol, 2005, 95(6): 593-599. |
| [31] | Danhier F, Feron O, Préat V. To exploit the tumor microenvironment;Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery[J]. J Control Release, 2010, 148(2): 135-146. |
| [32] | Cheng J, Zheng YF. In vitro study on newly designed biodegradable Fe-X composites(X=W, CNT)prepared by spark plasma sintering[J]. J Biomed Mater Res B Appl Biomater, 2013, 101(4): 485-497. |
| [33] | Hoskin P, Sartor O, O'Sullivan JM, et al. Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial[J]. Lancet Oncol, 2014, 15(12): 1397-1406. |
| [34] | Nieuweboer AJ, de Morrée ES, de Graan AJ, et al. Inter-patient variability in docetaxel pharmacokinetics: a review[J]. Cancer Treat Rev, 2015, 41(7): 605-613. |
